Education
About Us
Working with TipRanks
Follow Us
LGHT - ETF AI Analysis
Top Page
Langar Global HealthTech ETF (LGHT)
Rating:68Neutral
Price Target:―
Positive Factors
Focused HealthTech Theme
The ETF targets global health technology companies, giving investors concentrated exposure to a growing, innovation-driven area of healthcare.
Several Strong-Performing Core Holdings
Key positions such as Resmed, IQVIA, Philips, Dexcom, and BioNTech have shown strong year-to-date performance, helping support the fund’s overall results.
Broad Mix Within HealthTech Leaders
The top holdings include a mix of medical device makers, healthcare services, and biotech-related firms, which helps spread risk within the health technology space.
Negative Factors
High Expense Ratio
The fund’s relatively high fee means more of the investment return goes to costs instead of staying in investors’ pockets.
Heavy Concentration in a Few Stocks
A small number of companies make up a large share of the portfolio, so weakness in any of these names can significantly affect the ETF’s performance.
Narrow Sector and Geographic Exposure
With most assets in U.S. healthcare stocks, the ETF is vulnerable to downturns in that single sector and country rather than being cushioned by broader global or multi-sector diversification.
LGHT vs. SPDR S&P 500 ETF (SPY)
AUM3.86M
RegionGlobal
Expense Ratio0.85%
Beta0.94
IssuerLangar
Inception DateJan 10, 2024
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume527
30 Day Avg. Volume1,223
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
11.86Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering29
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
LGHT Summary
The Langar Global HealthTech ETF (LGHT) invests in companies using technology to improve healthcare, rather than tracking a traditional index. It focuses on health care technology, including digital health tools, telemedicine, medical devices, and biotech innovations. Well-known holdings include Intuitive Surgical and GE Healthcare Technologies. Someone might consider this ETF if they want long-term growth potential from advances in medical technology and a way to diversify within the healthcare sector. A key risk is that it is heavily concentrated in health care technology stocks, so its price can swing more than the overall market.
How much will it cost me?The Langar Global HealthTech ETF (LGHT) has an expense ratio of 0.85%, meaning you’ll pay $8.50 per year for every $1,000 invested. This is higher than average because it is actively managed, focusing on specialized healthcare technology companies rather than tracking a broad index.
What would affect this ETF?The Langar Global HealthTech ETF could benefit from growing demand for innovative healthcare solutions, such as telemedicine and advanced medical devices, driven by aging populations and technological advancements. However, it may face challenges from regulatory changes in healthcare, fluctuating global economic conditions, and potential competition within the health tech sector. Its global exposure and focus on leading companies like Intuitive Surgical and Siemens Healthineers position it well for long-term growth but also make it sensitive to international market volatility.
LGHT Top 10 Holdings
LGHT is a pure play on global health-tech, with performance heavily shaped by a few big names. Intuitive Surgical has been losing steam lately, acting as a bit of a brake on returns, while Insulet and Veeva are clearly lagging and adding pressure. On the brighter side, GE Healthcare and Zimmer Biomet have been rising, helping to steady the ship, with Dexcom offering a more mixed but generally supportive backdrop. With nearly everything tied to healthcare technology and spread across U.S. and international names, this ETF is both sector-focused and globally diversified.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Intuitive Surgical | 15.11% | $584.19K | $177.84B | -14.83% | 78 Outperform | |
| Resmed | 10.77% | $416.41K | $37.72B | 11.84% | 76 Outperform | |
| GE Healthcare Technologies Inc | 9.80% | $379.04K | $37.80B | -7.53% | 78 Outperform | |
| Insulet | 6.92% | $267.53K | $18.15B | -14.47% | 70 Outperform | |
| Veeva Systems | 6.85% | $264.88K | $29.79B | -20.14% | 66 Neutral | |
| Koninklijke Philips | 6.42% | $248.27K | $29.74B | 22.35% | 50 Neutral | |
| Dexcom | 5.40% | $208.64K | $28.02B | -17.68% | 79 Outperform | |
| IQVIA Holdings | 5.29% | $204.38K | $29.03B | -13.31% | 73 Outperform | |
| Siemens Healthineers AG Unsponsored ADR | 4.71% | $182.02K | $54.44B | -14.34% | 74 Outperform | |
| Zimmer Biomet Holdings | 4.27% | $165.11K | $19.47B | -5.80% | 73 Outperform |
LGHT Technical Analysis
Negative
―
Price Trends
9.98
Negative
10.09
Negative
10.18
Negative
Market Momentum
-0.15
Negative
45.71
Neutral
88.56
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For LGHT, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 9.73, equal to the 50-day MA of 9.98, and equal to the 200-day MA of 10.18, indicating a bearish trend. The MACD of -0.15 indicates Negative momentum. The RSI at 45.71 is Neutral, neither overbought nor oversold. The STOCH value of 88.56 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for LGHT.
LGHT Peer Comparison
Comparison Results
Performance Comparison
LGHT
Langar Global HealthTech ETF
9.67
-1.18
-10.88%
FMED
Fidelity Disruptive Medicine ETF
―
―
―
OZEM
Roundhill GLP-1 & Weight Loss ETF
―
―
―
HRTS
Tema Cardiovascular and Metabolic ETF
―
―
―
MEDI
Harbor Health Care ETF
―
―
―
GDOC
Goldman Sachs Future Health Care Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents